impedimed.com
Get leads like Impedimed — and thousands more
Build targeted lists by tech stack, traffic, and more
The Silent Guardian of Lymphedema
How ImpediMed's bioimpedance tech detects chronic disease before it's visible
In the $20B global lymphedema market, ImpediMed isn't selling devices—it's selling time. Their bioimpedance spectroscopy (BIS) technology detects fluid accumulation in tissue before it becomes clinically visible, turning early intervention from guesswork into science.
"ImpediMed isn't competing with diagnostic giants—they're creating a new category where early detection is the only defense."
The Patient Paradox
With only 9,052 monthly visits but 51% direct traffic, ImpediMed's audience isn't browsing—they're searching. The 440 monthly searches for 'impedimed' alone reveal a captive professional audience that knows exactly what they need. This isn't consumer-grade marketing; it's surgical precision targeting oncologists and physiotherapists who've seen lymphedema progress too far, too often.
The Funding Gap Story
Here's the contradiction that matters: $61.6M in funding but only $27.6M in revenue. That's a 2.2x funding-to-revenue ratio that screams 'growth mode'—but also 'burn mode.' For a 121-person company, they're spending heavily on R&D (Dennis Schlaht's domain) while commercializing slowly. The bet? That their 27% organic search traffic will convert into enterprise healthcare contracts before the cash runs dry.
The technology itself is elegant in its simplicity: measure how electrical currents travel through tissue at different frequencies. Water content changes impedance. Cancer treatments and surgery disrupt lymphatic flow. ImpediMed's BIS devices detect these changes weeks before swelling becomes visible. It's not magic—it's physics applied to a $10B+ problem that affects 1 in 1,000 people globally.
- BIS vs MFBIA: They're winning the technical debate—110 monthly searches for this comparison prove clinical curiosity
- Breast cancer survivors: 190 monthly searches for 'impedimed breast lymphedema' shows specific market penetration
- Direct traffic dominance: 51% direct vs 27% organic means their brand is remembered, not just discovered
The Quiet Disruptor
While giants chase AI diagnostics, ImpediMed owns a niche that matters: preventing lymphedema before it becomes permanent. Their 27% organic traffic isn't a weakness—it's proof of clinical adoption in a market that doesn't Google for answers. The real question isn't about their technology; it's whether $61.6M in funding is enough to scale from 121 employees to a medical device unicorn. The early data says they're betting on prevention over treatment—and that's a bet worth watching.
What tech stack does Impedimed use?
How much traffic does Impedimed get?
Traffic & Engagement
Traffic Sources
Where is Impedimed's audience located?
What keywords does Impedimed rank for?
5 keywordsHow is Impedimed's SEO?
Open Graph Image
https://www.impedimed.com/wp-content/uploads/2023/06/impedimed-sozo-digital-health-platform.jpg
Meta Tags
Medical Bioimpedance Spectroscopy (BIS) Devices | ImpediMed
ImpediMed’s bioimpedance spectroscopy (BIS) devices accurately and noninvasively aid for early detection, assessment, and intervention in chronic diseases.
H1 Tags
Schema Types
What is Impedimed's revenue?
Who works at Impedimed?
Loading leads...
What do customers think of Impedimed?
No Trustpilot reviews available for this company.
Frequently Asked Questions about Impedimed
What is Impedimed's Revenue?
What does Impedimed do?
How fast is Impedimed growing?
What technologies does Impedimed use?
Who are Impedimed's competitors?
Export Data
Unlock all exports
Download CSVs, JSONs & full reports
How to contact Impedimed?
Contact Information
Export impedimed.com Data
Download the complete tech stack, analytics, leads, and company data for impedimed.com in JSON or CSV format. Use it for your sales pipeline, competitive analysis, or research.
Raw JSON Data
Click "Show" to view the raw API response data
About impedimed.com
ImpediMed’s bioimpedance spectroscopy (BIS) devices accurately and noninvasively aid for early detection, assessment, and intervention in chronic diseases.
Company Overview
impedimed.com Social Media
Contact impedimed.com
Phone Numbers
Technology Stack
impedimed.com uses 16 technologies across their website including Google Fonts, HSTS, PHP, and more.
Fonts
Google Fonts
Security
HSTS
Programming Languages
PHP
CMS
WordPress
Advertising
DoubleClick Floodlight, Google Ads
Analytics & Marketing
Google Tag Manager, Google Analytics
Traffic & Audience
impedimed.com receives approximately 9.1K monthly visitors and ranks #2,487,390 globally. The website has a bounce rate of 43% with visitors viewing an average of 1.6 pages per visit. Users spend an average of 0:30 on the site.
The majority of impedimed.com's traffic comes from undefined, undefined, .
Frequently Asked Questions
What is impedimed.com?
What technologies does impedimed.com use?
How do I contact impedimed.com?
What are impedimed.com's social media accounts?
Is impedimed.com hiring?
How popular is impedimed.com?
Related Searches
This page provides publicly available information about impedimed.com. Data is collected from various public sources and may not always be up to date. For the most accurate information, please visit impedimed.com directly at https://impedimed.com.